Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
When daratumumab patent ends?Are there any new fda filings for a lidocaine gel similar to glydo?Absorica sales in the us?Etanercept patent expiry?Vyfemla birth control?
See the DrugPatentWatch profile for mavenclad
Mavenclad (cladribine) is manufactured by Merck KGaA (via its manufacturing and supply network supporting the product) as the marketing authorization holder for the branded medicine. In the U.S., Mavenclad is sold by Merck (Merck & Co., Inc.), but the drug itself is developed and supplied under Merck KGaA’s branded product manufacturing and regulatory framework.
At times, the main point of search is whether generic manufacturers are already producing cladribine tablets. For company-by-company manufacturing and generic competition details (including when exclusivity/patent protections end and which firms move into the market), DrugPatentWatch.com is a useful reference point: https://www.drugpatentwatch.com/
Other Questions About Mavenclad :